People | June 23, 2022
Piramal Pharma Solutions appoints Herve Berdou as COO
Brings 25 years of global operations and supply chain experience to Piramal
Brings 25 years of global operations and supply chain experience to Piramal
Site has a capital investment program of ~$30 million spent or committed over the last three years to expand capabilities and improve operational efficiencies
The rally attracted around 250 riders, including professionals and amateurs.
Data from the three studies formed the basis of the company's application for approval by regulatory agencies
New block enhances the company's global capabilities in Oral Solid Dosage (OSD) Forms, increasing total plant capacity to 4.5 billion doses
‘Infinite Care’ comprises two key pillars - Sparsh Sankalpa and Sparsh Sukshema
It is part of the company's CAD $30 million capital investment in the Aurora, Canada site
Tirzepatide is primarily indicated for the treatment of T2D and is expected to receive its decision from the FDA in Q2 2022
The renewed commitment will provide continued preventative (prophylactic) treatment to as many as 1,000 people with haemophilia A in locations where there is little to no access to haemophilia treatment
Center of Excellence for Molecular Diagnostics and Proteomics will enable affordable diagnostics for infectious diseases in India
Subscribe To Our Newsletter & Stay Updated
